Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179.
Infection of Vero cells with poliovirus results in complete disassembly of the Golgi complex. Milestones of the process of disassembly are the release to the cytosol of the beta-COP bound to Golgi membranes, the disruption of the cis-Golgi network into fragments scattered throughout the cytoplasm, and the disassembly of the stacked cisternae by a process mediated by long tubular structures. Transient expression of the viral protein 2B in COS-7 cells also causes the disassembly of the Golgi complex by a process preceded by the accumulation of the protein in the Golgi area. Vero cells infected for 3 h show no recognizable Golgi complexes at the ultrastructural level and display an enormously swollen endoplasmic reticulum (ER) with extensive areas of its surface heavily coated. Ro-090179 (Ro), a flavonoid isolated from the herb Agastache rugosa, provokes the specific swelling and disruption of the Golgi complex and strongly inhibits poliovirus infection. Ro provokes the swelling and the disruption of the stacked cisternae and trans-Golgi elements without affecting the cis-most Golgi cisternae much. Moreover, Ro inhibits the fusion of the Golgi complex with the ER in cells treated with brefeldin A and provokes the accumulation of the intermediate compartment membrane protein p58 into ERD2-positive Golgi elements but has no effect on the anterograde transport involved in protein secretion. Our results indicate that the secretory pathway and specifically the Golgi complex are preferential targets of poliovirus.
Sandoval
I V
IV
Centro de Biologia Molecular, Facultad de Ciencias, Universidad Autonoma de Madrid, Cantoblanco, Spain.
Carrasco
L
L
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D019556:COS Cells; D002451:Cell Compartmentation / Q000187:drug effects; D005419:Flavonoids / Q000494:pharmacology*; D006056:Golgi Apparatus / Q000187:drug effects* / Q000648:ultrastructure; D008561:Membrane Fusion; D008854:Microscopy, Electron; D011051:Poliomyelitis / Q000473:pathology*; D017955:Poliovirus / Q000472:pathogenicity*; D011794:Quercetin / Q000031:analogs & derivatives; D051381:Rats; D017361:Viral Nonstructural Proteins / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects
C101758:2B protein, poliovirus; D000998:Antiviral Agents; D005419:Flavonoids; D017361:Viral Nonstructural Proteins; C008751:pachypodol; D011794:Quercetin